Engineered therapeutic antibodies with enhanced effector functions: Clinical application of the Potelligent(R) Technology.
10.5045/kjh.2011.46.3.148
- Author:
Takefumi MATSUSHITA
1
Author Information
1. Department of Clinical Development, Kyowa Hakko Kirin Co., Ltd., Tokyo, Japan.
- Publication Type:Review
- MeSH:
Antibodies
- From:Korean Journal of Hematology
2011;46(3):148-150
- CountryRepublic of Korea
- Language:English
-
Abstract:
No abstract available.